Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Roche licensed a Chinese biotech's obesity drug in a deal worth up to $1.16 billion

The Swiss drugmaker will pay up to $100 million upfront to license an RNAi therapy targeting fat tissue from Shanghai-based Rona Therapeutics

Roche licensed a Chinese biotech's obesity drug in a deal worth up to $1.16 billion

We haven't written up this one. Quartz has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at qz.com →

More in Health & Medicine

Pope Leo XIV’s cancer diagnosis casts doubt on South America trip

The pontiff’s lung surgery has raised questions about his recovery ahead of a November visit to Argentina, Uruguay and Peru La entrada Pope Leo XIV’s cancer diagnosis casts doubt on South America trip…

  • Pope Leo XIV diagnosed with lung cancer
  • Surgery performed on October 13 at Rome's Gemelli Hospital
  • South America trip to Uruguay, Argentina, and Peru remains planned

Tanzania: Nyerere's Healthcare Vision Endures Amid Service Expansion

[Daily News] Dar es Salaam -- WHEN Tanzania gained independence in 1961, access to healthcare remained a major challenge, particularly for rural communities where medical facilities were scarce and…

  • President Julius Nyerere viewed healthcare as key to eradicating poverty and ignorance.
  • Government investments increased patient beds by 82% and ICU beds by 1,515% from 2021 to 2024.

More from Wednesday 14 October →